# QT-prolongation in Psychiatric Hospitals

> **NCT02043925** · — · COMPLETED · sponsor: **KU Leuven** · enrollment: 152 (actual)

## Conditions studied

- QT-prolongation

## Interventions

- **DRUG:** drugs linked with QT-prolongation

## Key facts

- **NCT ID:** NCT02043925
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2015-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02043925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02043925, "QT-prolongation in Psychiatric Hospitals". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02043925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
